Crizotinib, an Effective Agent in <i>ROS1</i>-Rearranged Adenocarcinoma of Lungs: A Case Report.
| Author | |
|---|---|
| Abstract |
:
ROS1 rearrangement has recently emerged as a new molecular subtype in non-small-cell lung cancer (NSCLC) and is predominantly found in lung adenocarcinoma compared with other oncogenes such as EGFR, KRAS, or ALK. It has been identified in only 1% to 2% of NSCLC cases. |
| Year of Publication |
:
0
|
| Journal |
:
Clinical medicine insights. Case reports
|
| Volume |
:
11
|
| Number of Pages |
:
1179547617749615
|
| Date Published |
:
2018
|
| DOI |
:
10.1177/1179547617749615
|
| Short Title |
:
Clin Med Insights Case Rep
|
| Download citation |
